Citations 3
636 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc T cell engager in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Uboha, Nataliya V. , Chaves, Jorge, Chen, Christopher T. , Powderly, John D. , Zhaohui, Jin, Alistar, Angela , Gabrail, Nashat , Agensky, Laura, Goel, Apollina, Margossian, Steven, Levisetti, Matteo, Quayle, Steve, Kim, Dae Won , Alese, Olatunji B. , Saenger, Yvonne M. , Zheng, Lei , Fu, Siqing , Gong, Jun , Zhaohui, Jin, Bekaii‐Saab, Tanios , Selfridge, Jennifer Eva
Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A730-A730
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Uboha, Nataliya V. , Chaves, Jorge, Powderly, John D. , Gabrail, Nashat , Zhaohui, Jin, Alistar, Angela , Agensky, Laura, Goel, Apollina, Margossian, Steven, Quayle, Steve, Levisetti, Matteo, Selfridge, Jennifer Eva , Saenger, Yvonne M. , Zheng, Lei , Kim, Dae Won , Alese, Olatunji B. , Fu, Siqing , Gong, Jun , Zhaohui, Jin, Bekaii‐Saab, Tanios
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A846-A846
636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Margossian, Steven, Powderly, John , Gabrail, Nashat , Uboha, Nataliya V. , Ma, Wen , Jones, Jeremy , Alistar, Angela , Agensky, Laura, Goel, Apollina, Lynam, Reena, Moniz, Raymond J., Quayle, Steve, Rajan, Cynthia, Levisetti, Matteo, Jones, Jeremy C , Saenger, Yvonne M. , Selfridge, Jennifer Eva , Gong, Jun , Tine, Brian A. Van , Alese, Olatunji B. , Kim, Dae Won , Bekaii‐Saab, Tanios , Pienta, Kenneth J
Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A667-A667